Lille, France

François Trottein

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: François Trottein: Innovator in Pharmaceutical Treatments

Introduction

François Trottein is a notable inventor based in Lille, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial superinfections following influenza. His innovative approach has the potential to improve patient outcomes in critical healthcare scenarios.

Latest Patents

Trottein holds a patent for "Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza." This invention focuses on a method of treating bacterial superinfections in subjects who have suffered from influenza. The treatment involves administering a therapeutically effective amount of a flagellin polypeptide, which may be combined with at least one antibiotic. This patent highlights Trottein's commitment to advancing medical science and addressing urgent health challenges.

Career Highlights

Throughout his career, François Trottein has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Trottein has collaborated with notable colleagues, including Jean-Claude Sirard and Christophe Carnoy. These partnerships have fostered an environment of innovation and have been instrumental in the development of his research and patents.

Conclusion

François Trottein's contributions to pharmaceutical innovations, particularly in treating bacterial superinfections post-influenza, underscore his role as a significant inventor in the medical field. His work continues to inspire advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…